An open label, single-centric, non-randomized clinical study to evaluate the safety and efficacy of a new antimicrobial wound dressing (VELVERT) as an adjuvant therapy in patients having Necrotising soft-tissue infections (NSTI)/ fasciitis - Nil
An open label, single-centric, post market clinical study to evaluate the safety and efficacy of a new antimicrobial wound dressing (VELVERT) as an adjuvant therapy in the treatment of venous leg ulcer. - NIL
A post-marketing surveillance multi-centric study to evaluate quality, safety and performance of VELFIX® EDGE plus CHG a cannula securement patch dressing in Reducing catheter Related Bloodstream Infection.
100 项与 Datt Mediproducts Pvt Ltd. 相关的临床结果
0 项与 Datt Mediproducts Pvt Ltd. 相关的专利(医药)
100 项与 Datt Mediproducts Pvt Ltd. 相关的药物交易
100 项与 Datt Mediproducts Pvt Ltd. 相关的转化医学